155 related articles for article (PubMed ID: 17260147)
1. CHIH-DFT determination of the molecular structure infrared spectra, UV spectra and chemical reactivity of three antitubercular compounds: Rifampicin, Isoniazid and Pyrazinamide.
Favila A; Gallo M; Glossman-Mitnik D
J Mol Model; 2007 Apr; 13(4):505-18. PubMed ID: 17260147
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of rifampicin, isoniazid and pyrazinamide in tablet preparations by multivariate spectrophotometric calibration.
Goicoechea HC; Olivieri AC
J Pharm Biomed Anal; 1999 Aug; 20(4):681-6. PubMed ID: 10704137
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs.
Bhutani H; Singh S; Jindal KC; Chakraborti AK
J Pharm Biomed Anal; 2005 Oct; 39(5):892-9. PubMed ID: 15978767
[TBL] [Abstract][Full Text] [Related]
4. Liquid chromatographic determination of isoniazid, pyrazinamide and rifampicin from pharmaceutical preparations and blood.
Khuhawar MY; Rind FM
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(2):357-63. PubMed ID: 11829003
[TBL] [Abstract][Full Text] [Related]
5. [Application of near infrared spectroscopy in rapid and simultaneous determination of essential components in five varieties of anti-tuberculosis tablets].
Teng LS; Wang D; Song J; Zhang YB; Guo WL; Teng LR
Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Aug; 28(8):1814-8. PubMed ID: 18975810
[TBL] [Abstract][Full Text] [Related]
6. Probing location of anti-TB drugs loaded in Brij 96 microemulsions using thermoanalytical and photophysical approach.
Kaur G; Mehta SK
J Pharm Sci; 2014 Mar; 103(3):937-44. PubMed ID: 24425102
[TBL] [Abstract][Full Text] [Related]
7. Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method.
Panchagnula R; Sood A; Sharda N; Kaur K; Kaul CL
J Pharm Biomed Anal; 1999 Jan; 18(6):1013-20. PubMed ID: 9925337
[TBL] [Abstract][Full Text] [Related]
8. Dissolution testing of isoniazid, rifampicin, pyrazinamide and ethambutol tablets using near-infrared spectroscopy (NIRS) and multivariate calibration.
de Oliveira Neves AC; Soares GM; de Morais SC; da Costa FS; Porto DL; de Lima KM
J Pharm Biomed Anal; 2012 Jan; 57():115-9. PubMed ID: 21908131
[TBL] [Abstract][Full Text] [Related]
9. CHIH-DFT determination of the molecular structure and IR and UV spectra of solanidine.
Glossman-Mitnik D
J Mol Model; 2007 Jan; 13(1):43-6. PubMed ID: 16724197
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous determination of rifampicin, isoniazid and pyrazinamid by high performance thin layer chromatography.
Argekar AP; Kunjir SS; Purandare KS
J Pharm Biomed Anal; 1996 Aug; 14(11):1645-50. PubMed ID: 8877875
[No Abstract] [Full Text] [Related]
11. Validation of a RP-LC method for the simultaneous determination of isoniazid, pyrazinamide and rifampicin in a pharmaceutical formulation.
Calleri E; De Lorenzi E; Furlanetto S; Massolini G; Caccialanza G
J Pharm Biomed Anal; 2002 Aug; 29(6):1089-96. PubMed ID: 12110394
[TBL] [Abstract][Full Text] [Related]
12. Determination of antitubercular drugs by micellar electrokinetic capillary chromatography (MEKC).
Acedo-Valenzuela MI; Espinosa-Mansilla A; Muñoz De La Peña A; Cañada-Cañada F
Anal Bioanal Chem; 2002 Oct; 374(3):432-6. PubMed ID: 12373391
[TBL] [Abstract][Full Text] [Related]
13. CHIH-DFT determination of the molecular structure and infrared and ultraviolet spectra of gamma-solanine.
Glossman-Mitnik D
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Jan; 66(1):208-11. PubMed ID: 16859976
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
Prahl JB; Lundqvist M; Bahl JM; Johansen IS; Andersen ÅB; Frimodt-Møller N; Cohen AS
APMIS; 2016 Nov; 124(11):1004-1015. PubMed ID: 27546025
[TBL] [Abstract][Full Text] [Related]
15. The colorimetric analysis of anti-tuberculosis fixed-dose combination tablets and capsules.
Ellard GA
Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S343-6; discussion S351-2. PubMed ID: 10593715
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of rifampicin and isoniazid by continuous-flow chemiluminescence with artificial neural network calibration.
Li B; He Y; Lv J; Zhang Z
Anal Bioanal Chem; 2005 Nov; 383(5):817-24. PubMed ID: 16205895
[TBL] [Abstract][Full Text] [Related]
17. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
Dekker TG; Lötter AP
Int J Tuberc Lung Dis; 2003 Mar; 7(3):205-6. PubMed ID: 12661831
[No Abstract] [Full Text] [Related]
18. Evaluation of the recently reported USP gradient HPLC method for analysis of anti-tuberculosis drugs for its ability to resolve degradation products of rifampicin.
Mohan B; Sharda N; Singh S
J Pharm Biomed Anal; 2003 Mar; 31(3):607-12. PubMed ID: 12615251
[TBL] [Abstract][Full Text] [Related]
19. Overestimation of rifampicin during colorimetric analysis of anti-tuberculosis products containing isoniazid due to formation of isonicotinyl hydrazone.
Mariappan TT; Jindal KC; Singh S
J Pharm Biomed Anal; 2004 Nov; 36(4):905-8. PubMed ID: 15533688
[TBL] [Abstract][Full Text] [Related]
20. Optimization of a reversed-phase-high-performance thin-layer chromatography method for the separation of isoniazid, ethambutol, rifampicin and pyrazinamide in fixed-dose combination antituberculosis tablets.
Shewiyo DH; Kaale E; Risha PG; Dejaegher B; Smeyers-Verbeke J; Vander Heyden Y
J Chromatogr A; 2012 Oct; 1260():232-8. PubMed ID: 22981506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
